The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains

Journal of Virology

Volumn 86, Issue 15, 2012, Pages 8210-8220

  Chan, Winnie M ^a,b   Ward, Brian M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A33 PROTEIN; B5 PROTEIN; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHIMERA; CONTROLLED STUDY; MEMBRANE STRUCTURE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RESIDUE ANALYSIS; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRION; VIRUS ENVELOPE; VIRUS RELEASE;

HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; VACCINIA; VACCINIA VIRUS; VIRAL MATRIX PROTEINS; VIRION;

EID: 84864380568     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00249-12     Document Type: Article

References (58)

1. Appleyard G, Hapel AJ, Boulter EA. 1971. An antigenic difference between intracellular and extracellular rabbitpox virus. J. Gen. Virol. 13:9-17.
2. Blasco R, Moss B. 1991. Extracellular vaccinia virus formation and cellto-cell virus transmission are prevented by deletion of the gene encoding the 37,000-dalton outer envelope protein. J. Virol. 65:5910-5920.
3. Chan WM, Kalkanoglu AE, Ward BM. 2010. The inability of vaccinia virus A33R protein to form intermolecular disulfide-bonded homodimers does not affect the production of infectious extracellular virus. Virology 408:109-118.
4. Chan WM, Ward BM. 2012. Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production. J. Virol. 86:8232-8244.
5. Chan WM, Ward BM. 2010. There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions. Virology 402:83-93.
6. Chen Y, et al. 2009. Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis. Virol. J. 6:44.
7. Condit RC, Moussatche N, Traktman P. 2006. In a nutshell: structure and assembly of the vaccinia virion. Adv. Virus Res. 66:31-124.
8. Duncan SA, Smith GL. 1992. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J. Virol. 66:1610-1621.
9. Earl PL, Moss B. 1991. Generation of recombinant vaccinia viruses, p 16.17.11-16.17.16. In Ausubel FM, et al. (ed), Current protocols in molecular biology, vol 2. Greene Publishing Associates & Wiley Interscience, New York, NY.
10. Earley AK, Chan WM, Ward BM. 2008. The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J. Virol. 82:2161-2169.
11. Engelstad M, Howard ST, Smith GL. 1992. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188:801-810.
12. Engelstad M, Smith GL. 1993. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194:627-637.
13. Geada MM, Galindo I, Lorenzo MM, Perdiguero B, Blasco R. 2001. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J. Gen. Virol. 82:2747-2760.
14. Herrera E, del Mar Lorenzo M, Blasco R, Isaacs SN. 1998. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J. Virol. 72:294-302.
15. Hiller G, Weber K. 1985. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J. Virol. 55:651-659.
16. Hiller G, Weber K, Schneider L, Parajsz C, Jungwirth C. 1979. Interaction of assembled progeny pox viruses with the cellular cytoskeleton. Virology 98:142-153.
17. Hollinshead M, et al. 2001. Vaccinia virus utilizes microtubules for movement to the cell surface. J. Cell Biol. 154:389-402.
18. Hooper JW, Custer DM, Schmaljohn CS, Schmaljohn AL. 2000. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology 266:329-339.
19. Hume AN, Tarafder AK, Ramalho JS, Sviderskaya EV, Seabra MC. 2006. A coiled-coil domain of melanophilin is essential for myosin Va recruitment and melanosome transport in melanocytes. Mol. Biol. Cell 17:4720-4735.
20. Husain M, Moss B. 2002. Similarities in the induction of post-Golgi vesicles by the vaccinia virus F13L protein and phospholipase D. J. Virol. 76:7777-7789.
21. Isaacs SN, Wolffe EJ, Payne LG, Moss B. 1992. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 66:7217-7224.
22. Johnston SC, Ward BM. 2009. Vaccinia virus protein F12 associates with intracellular enveloped virions through an interaction with A36. J. Virol. 83:1708-1717.
23. Katz E, Ward BM, Weisberg AS, Moss B. 2003. Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein. J. Virol. 77: 12266-12275.
24. Katz E, Wolffe E, Moss B. 2002. Identification of second-site mutations that enhance release and spread of vaccinia virus. J. Virol. 76:11637-11644.
25. Lorenzo MD, Herrera E, Blasco R, Isaacs SN. 1998. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail. Virology 252: 450-457.
26. Moss B. 2001. Poxviridae: the viruses and their replication, p 2849-2883. In Fields BN, Knipe DM, Howley PM (ed), Fields virology, fourth ed, vol Lippincott-Raven Publishers, Philadelphia, PA.
27. Moss B. 2006. Poxvirus entry and membrane fusion. Virology 344:48-54.
28. Newsome TP, Scaplehorn N, Way M. 2004. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 306:124-129.
29. Payne LG. 1992. Characterization of vaccinia virus glycoproteins by monoclonal antibody preparations. Virology 187:251-260.
30. Payne LG. 1980. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol. 50:89-100.
31. Perdiguero B, Blasco R. 2006. Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins. J. Virol. 80:8763-8777.
32. Perdiguero B, Lorenzo MM, Blasco R. 2008. Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope. J. Virol. 82:2150-2160.
33. Rietdorf J, et al. 2001. Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat. Cell Biol. 3:992-1000.
34. Roberts KL, et al. 2009. Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycanmediated disruption of the extracellular enveloped virus outer membrane. J. Gen. Virol. 90:1582-1591.
35. Roberts KL, Smith GL. 2008. Vaccinia virus morphogenesis and dissemination. Trends Microbiol. 16:472-479.
36. Roper RL, Payne LG, Moss B. 1996. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 70:3753-3762.
37. Roper RL, Wolffe EJ, Weisberg A, Moss B. 1998. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 72: 4192-4204.
38. Röttger S, Frischknecht F, Reckmann I, Smith GL, Way M. 1999.Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J. Virol. 73:2863-2875.
39. Reference deleted
40. Schmelz M, et al. 1994. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J. Virol. 68:130-147.
41. Schmidt TG, Skerra A. 2007. The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins. Nat. Protoc. 2:1528-1535.
42. Shida H. 1986. Nucleotide sequence of the vaccinia virus hemagglutinin gene. Virology 150:451-462.
43. Smith GL, Vanderplasschen A, Law M. 2002. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83:2915-2931.
44. Stokes GV. 1976. High-voltage electron microscope study of the release of vaccinia virus from whole cells. J. Virol. 18:636-643.
45. Tooze J, Hollinshead M, Reis B, Radsak K, Kern H. 1993. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 60:163-178.
46. Turner PC, Moyer RW. 2006. The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells. Virology 347:88-99.
47. van Eijl H, Hollinshead M, Rodger G, Zhang WH, Smith GL. 2002. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J. Gen. Virol. 83:195-207.
48. van Eijl H, Hollinshead M, Smith GL. 2000. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology 271:26-36.
49. Wagenaar TR, Moss B. 2007. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J. Virol. 81:6286-6293.
50. Ward BM. 2005. Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions. J. Virol. 79:4755-4763.
51. Ward BM, Moss B. 2000. Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein. J. Virol. 74:3771-3780.
52. Ward BM, Moss B. 2001. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J. Virol. 75: 11651-11663.
53. Ward BM, Moss B. 2001. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J. Virol. 75:4802-4813.
54. Ward BM, Weisberg AS, Moss B. 2003. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J. Virol. 77:4113-4126.
55. Wolffe EJ, Isaacs SN, Moss B. 1993. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 67:4732-4741.
56. Wolffe EJ, Weisberg AS, Moss B. 1998. Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread. Virology 244:20-26.
57. Wolffe EJ, Weisberg AS, Moss B. 2001. The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J. Virol. 75:303-310.
58. Zhang WH, Wilcock D, Smith GL. 2000. Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J. Virol. 74:11654-11662.